Just been searching the net for any news and came across the EMA report on the reasons why they could not approve.
http://www.ema.europa.eu/docs/en_GB/document_library/Application_withdrawal_assessment_report/2011/03/WC500103707.pdf
Have not seen this before and if I had I would have sold long ago.
I wonder why CXS did not report this! You would have thought this was sensistive information???
No wonder CXS management are keen on selling, it seems quite a long haul to get this approved, can't see too many biotechs lining up to offer more considering the risks they would be taking on.
Anyway good luck to those that still hold, and if you are fortunate enough to still be in profit perhaps it's time not to be so greedy.
Cheers all signing out on this one... it's been one helluva a learning experience.
Add to My Watchlist
What is My Watchlist?